Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Acetazolamide Sodium

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: Sodium acetazolamide, 1424-27-7, Acetazolamide sodium salt, Acetazolamide sodium [jan], Chebi:31163, N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide monosodium salt
    Molecular Formula
    C4H5N4NaO3S2
    Molecular Weight
    244.2  g/mol
    InChI Key
    MRSXAJAOWWFZJJ-UHFFFAOYSA-M
    FDA UNII
    429ZT169UH
    Acetazolamide Sodium is the sodium salt of acetazolamide, a nonbacteriostatic sulfonamide derivative with diuretic and anticonvulsant properties. Acetazolamide is a potent inhibitor of carbonic anhydrase that plays an important role in the control of fluid secretion. Inhibition of this enzyme in the kidney results in a reduction in the availability of hydrogen ions for active transport in the renal tubule lumen, thereby leading to increased bicarbonate and cation excretion, and increased urinary volume. Reduced bicarbonate level in circulation induces reduction of intraocular pressure via osmotic mechanism. The anticonvulsant activity of acetazolamide may contribute to inhibition of carbonic anhydrase in the CNS, which decreases carbon dioxide tension in the pulmonary alveoli, thus increasing arterial oxygen tension.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    sodium;(5-acetamido-1,3,4-thiadiazol-2-yl)sulfonylazanide
    2.1.2 InChI
    InChI=1S/C4H6N4O3S2.Na/c1-2(9)6-3-7-8-4(12-3)13(5,10)11;/h1H3,(H3,5,6,7,9,10,11);/q;+1/p-1
    2.1.3 InChI Key
    MRSXAJAOWWFZJJ-UHFFFAOYSA-M
    2.1.4 Canonical SMILES
    CC(=O)NC1=NN=C(S1)S(=O)(=O)[NH-].[Na+]
    2.2 Other Identifiers
    2.2.1 UNII
    429ZT169UH
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. Sodium Acetazolamide

    2. 1424-27-7

    3. Acetazolamide Sodium Salt

    4. Acetazolamide Sodium [jan]

    5. Chebi:31163

    6. N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide Monosodium Salt

    7. 429zt169uh

    8. Sodium;(5-acetamido-1,3,4-thiadiazol-2-yl)sulfonylazanide

    9. Diamox (tn)

    10. Acetamide, N-(5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl)-, Monosodium Salt

    11. Acetazolamide Sodium (jan)

    12. Schembl40813

    13. Unii-429zt169uh

    14. Chembl1200814

    15. Dtxsid00162031

    16. Acetazolamide Sodium [vandf]

    17. Acetazolamide Sodium [mart.]

    18. Acetazolamide Sodium [who-dd]

    19. Acetamide, N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)-, Monosodium Salt

    20. Acetazolamide Sodium Salt [mi]

    21. Acetazolamide Sodium [green Book]

    22. Acetazolamide Sodium [orange Book]

    23. D01196

    24. Q27114185

    25. Sodium [(5-acetamido-1,3,4-thiadiazol-2-yl)sulfonyl]azanide

    2.4 Create Date
    2007-02-08
    3 Chemical and Physical Properties
    Molecular Weight 244.2 g/mol
    Molecular Formula C4H5N4NaO3S2
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count7
    Rotatable Bond Count2
    Exact Mass243.97007666 g/mol
    Monoisotopic Mass243.97007666 g/mol
    Topological Polar Surface Area127 Ų
    Heavy Atom Count14
    Formal Charge0
    Complexity302
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 2  
    Drug NameAcetazolamide sodium
    PubMed HealthAcetazolamide sodium
    Active IngredientAcetazolamide sodium
    Dosage FormInjectable
    RouteInjection
    Strengtheq 500mg base/vial
    Market StatusPrescription
    CompanySagent Agila; X Gen Pharms; Eurohlth Intl

    2 of 2  
    Drug NameAcetazolamide sodium
    PubMed HealthAcetazolamide sodium
    Active IngredientAcetazolamide sodium
    Dosage FormInjectable
    RouteInjection
    Strengtheq 500mg base/vial
    Market StatusPrescription
    CompanySagent Agila; X Gen Pharms; Eurohlth Intl

    5 Pharmacology and Biochemistry
    5.1 FDA Pharmacological Classification
    5.1.1 Pharmacological Classes
    Carbonic Anhydrase Inhibitors [MoA]; Sulfonamides [CS]; Carbonic Anhydrase Inhibitor [EPC]